Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Toxicol In Vitro ; 23(7): 1396-405, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19619636

RESUMEN

Bis-(beta-chloroethyl) sulfide (SM) is a potent skin vesicant previously used for chemical warfare. Progress in determination of the mechanistic basis of SM pathology, and development of prophylactic and/or therapeutic countermeasures to SM exposure has been hampered by lack of physiologically relevant models of human skin. The current work evaluated a newly developed tissue engineered full-thickness human skin model in a completely in vitro approach to investigation of SM-induced dermal pathology. The model was first characterized with regard to overall morphology, lipid composition, basement membrane (BM) composition and ultrastructural features that are important targets of SM pathologic activity. Well-developed BM ultrastructural features were observed at the dermal-epidermal junction (DEJ), thus demonstrating successful resolution of a primary deficiency of models previously evaluated for SM studies. Studies were then conducted to evaluate histopathological effects of SM on the model. Good replication of in vivo effects was observed, including apoptosis of basal keratinocytes (KC) and microblister formation at the DEJ. Tissue engineered skin models with well-developed basement membrane structures thus appear to be useful tools for in vitro mechanistic studies of SM vesicant activity and development of preventive/therapeutic approaches for SM pathology.


Asunto(s)
Vesícula/inducido químicamente , Sustancias para la Guerra Química/toxicidad , Modelos Biológicos , Gas Mostaza/toxicidad , Piel/efectos de los fármacos , Pruebas de Toxicidad/métodos , Membrana Basal/metabolismo , Membrana Basal/ultraestructura , Vesícula/patología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibroblastos/ultraestructura , Humanos , Técnicas In Vitro , Lípidos/química , Proteínas de la Membrana/metabolismo , Piel/metabolismo , Piel/ultraestructura
2.
J Invest Dermatol ; 128(9): 2190-7, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18385757

RESUMEN

PKCzeta (protein kinase C-zeta), a member of protein kinase C family, plays an important role in cell proliferation, differentiation, and apoptosis. It acts as a downstream molecule for TNF-alpha (tumor necrosis factor) signal transduction and also regulates the expression of CD1d, an HLA-class I-like molecule. The interaction of CD1d with natural killer T (NKT) cells has been shown to be important in their Th1 cytokine production in psoriasis. In this study, we examined PKCzeta in psoriasis in order to define its role in the pathogenesis of the disease. We found that T-cell receptor (TCR) V alpha24+ V beta11+ NKT cells and CD1d molecules within psoriatic skin were increased. Moreover, there was an associated increase in PKCzeta mRNA and protein expression with membrane translocation in psoriasis lesions compared to uninvolved skin. Furthermore, cultured keratinocytes exhibited increased PKCzeta activity and membrane translocation upon stimulation by TNF-alpha, a cytokine known to play an important role in the pathogenesis of psoriasis. These results implied that PKCzeta is an important transduction molecule downstream of TNF-alpha signaling and is associated with increased expression of CD1d that may enhance CD1d-NKT cell interactions in psoriasis lesions. This makes PKCzeta a tempting target for possible pharmacological intervention in modifying the downstream effects of TNF-alpha in psoriasis.


Asunto(s)
Queratinocitos/enzimología , Proteína Quinasa C/metabolismo , Psoriasis/enzimología , Antígenos CD1/metabolismo , Antígenos CD1d , Línea Celular , Células Cultivadas , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Humanos , Queratinocitos/efectos de los fármacos , Queratinocitos/patología , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/metabolismo , Células Asesinas Naturales/patología , Masculino , Psoriasis/etiología , Psoriasis/patología , ARN Mensajero/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Factor de Necrosis Tumoral alfa/metabolismo , Factor de Necrosis Tumoral alfa/farmacología
3.
J Cutan Pathol ; 35(9): 849-54, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18422973

RESUMEN

An 88-year-old white male presented with a rapidly growing skin nodule on the scalp. Clinically, the nodule did not appear unusual for an ordinary cutaneous neoplasm on sun-exposed skin of an elderly white male. Histopathological examination showed sheet-like epithelioid tumor cell growth with a vaguely nested pattern and frank malignant features, resembling malignant melanoma. However, the tumor cells possessed irregularly convoluted nuclei with nuclear groves, frequent multinucleation and fine vesicular cytoplasm, features highly suggestive of histiocytes. Immunohistochemistry studies showed that the tumor cells were diffusely positive for S-100 protein and CD1a and negative for HMB-45, Melan-A, cytokeratin and CD30. The provisional diagnosis of Langerhans cell sarcoma was thus favored. To confirm this diagnosis, electron microscopic examination was performed. Although classic features of histiocytes were readily identifiable, no Birbeck granules could be found upon a thorough search on repeated sections. These results are indicative of the indeterminate cell nature of the tumor. We propose a diagnosis of primary cutaneous indeterminate cell sarcoma for this unusual histiocytic neoplasm. Current classification of histiocytic neoplasms and differential diagnosis are reviewed.


Asunto(s)
Sarcoma de Células de Langerhans/patología , Células de Langerhans/patología , Neoplasias Cutáneas/patología , Anciano de 80 o más Años , Antígenos CD1/análisis , Biomarcadores de Tumor/análisis , Núcleo Celular/ultraestructura , Gránulos Citoplasmáticos/ultraestructura , Histiocitos/ultraestructura , Humanos , Técnicas para Inmunoenzimas , Sarcoma de Células de Langerhans/metabolismo , Sarcoma de Células de Langerhans/cirugía , Células de Langerhans/química , Masculino , Proteínas S100/análisis , Cuero Cabelludo , Neoplasias Cutáneas/química , Neoplasias Cutáneas/cirugía
4.
Microsc Microanal ; 11(2): 175-80, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15817147

RESUMEN

The present study was designed to evaluate the efficacy of different microwave pretreatment methods to retrieve microtubule-associated protein 2 (MAP-2) immunoreactivity in formalin-fixed, paraffin-embedded guinea pig brain sections. Brain sections, microwave pretreated in boiling sodium citrate, citric acid, Tris hydrochloride, and EDTA buffers of pH 4, 6, and 8, were labeled with four different clones of MAP-2 monoclonal antibodies. No MAP-2 immunoreactivity was observed in control sections processed without microwave pretreatment. Optimal MAP-2 immunoreactivity was observed only when MAP-2 antibody clone AP18 was used in conjunction with citric acid buffer of pH 6.0. Using this combination, brain sections from nerve agent soman-exposed guinea pigs were found to exhibit marked reduction in MAP-2 immunostaining in the hippocampus. These observations suggest that the clone of the antibody in addition to the type and pH of antigen retrieval (AR) solution are important variables to be considered for establishing an optimal AR technique. When studying counterpart antigens of species other than that to which the antibodies were originally raised, different antibody clones must be tested in combination with different microwave-assisted AR (MAR) methods. This MAR method makes it possible to conduct retrospective studies on archival guinea pig brain paraffin blocks to evaluate changes in neuronal MAP-2 expression as a consequence of chemical warfare nerve agent toxicity.


Asunto(s)
Encéfalo/metabolismo , Proteínas Asociadas a Microtúbulos/metabolismo , Animales , Anticuerpos Monoclonales , Antígenos/inmunología , Tampones (Química) , Sustancias para la Guerra Química/toxicidad , Cobayas , Inmunohistoquímica/métodos , Masculino , Proteínas Asociadas a Microtúbulos/análisis , Microondas , Soman/toxicidad , Adhesión del Tejido , Fijación del Tejido
5.
Toxicol Pathol ; 31(2): 185-90, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12696578

RESUMEN

The present study was aimed to examine whether apoptosis is involved in the pathogenesis of sulfur mustard (SM)-induced basal cell death. Skin sites of the hairless guinea pig exposed to SM vapor for 8 minutes were harvested at 3, 6, 12, 24, and 48 hours postexposure. Immunohistochemical detection of basal cell apoptosis was performed using the ApopTag in situ apoptosis labeling kit. Only occasional apoptotic basal cells (BC)were observed in nonexposed and perilesional control sites. At lesional sites, apoptosis of BC was not detected at 3 hours postexposure. However, at 6 hours and 12 hours postexposure, 18% and 59% of BC were apoptotic, respectively. At 24 and 48 hours postexposure, individual apoptotic basal cells were not clearly recognizable due to necrosis. At the ultrastructural level, degenerating BC exhibited typical apoptotic morphology including nuclear condensation and chromatin margination. The results suggest that apoptotic cell death is a cytotoxic mechanism with the number of BC undergoing apoptosis significantly increasing from 6 to 12 hours postexposure. In addition, because necrosis is preferential at 24 hours postexposure, we believe that SM-induced cell death involves early apoptosis and late necrosis, which temporally overlap to produce a single cell death pathway along an apoptotic-necrotic continuum.


Asunto(s)
Apoptosis/efectos de los fármacos , Sustancias para la Guerra Química/toxicidad , Queratinocitos/patología , Gas Mostaza/toxicidad , Piel/efectos de los fármacos , Administración Cutánea , Animales , Recuento de Células , Fragmentación del ADN , Cobayas , Técnicas para Inmunoenzimas , Etiquetado Corte-Fin in Situ , Queratinocitos/efectos de los fármacos , Queratinocitos/ultraestructura , Masculino , Gas Mostaza/administración & dosificación , Piel/patología , Factores de Tiempo , Volatilización
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA